Cargando…

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan

IMPORTANCE: Chronic hepatitis C virus (HCV) infection is a global health problem. The World Health Assembly recently pledged to eliminate HCV by 2030. However, in Pakistan, a country with one of the highest prevalence rates, the feasibility and cost of HCV elimination are not known. OBJECTIVES: To i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chhatwal, Jagpreet, Chen, Qiushi, Wang, Xiaojie, Ayer, Turgay, Zhuo, Yueran, Janjua, Naveed Z., Kanwal, Fasiha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512462/ https://www.ncbi.nlm.nih.gov/pubmed/31074817 http://dx.doi.org/10.1001/jamanetworkopen.2019.3613

Ejemplares similares

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
por: Chen, Qiushi, et al.
Publicado: (2020)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
por: Aggarwal, Rakesh, et al.
Publicado: (2017)

Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2021)

Author Correction: Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2022)

Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US
por: Kulkarni, Neeti S., et al.
Publicado: (2023)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions
por: Linas, Benjamin P., et al.
Publicado: (2022)

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model
por: Binka, Mawuena, et al.
Publicado: (2020)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
por: Chen, Wanyi, et al.
Publicado: (2022)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)

Artificial Neural Networks in Mammography Interpretation and Diagnostic Decision Making
por: Ayer, Turgay, et al.
Publicado: (2013)

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
por: Chen, Qiushi, et al.
Publicado: (2019)

The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia
por: Ho, Harriet, et al.
Publicado: (2021)

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
por: Ferrante, Shannon Allen, et al.
Publicado: (2013)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
por: Odhiambo, Raymond, et al.
Publicado: (2013)

Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Costs and financial feasibility of malaria elimination
por: Sabot, Oliver, et al.
Publicado: (2010)

When Can We Lift Non‐Pharmaceutical Interventions with the Availability of COVID‐19 Vaccine in the United States?
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion
por: Wilton, James, et al.
Publicado: (2022)

Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire
por: Blake, Andrew, et al.
Publicado: (2021)

Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation
por: Mera, Jorge, et al.
Publicado: (2020)

Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus–Associated Cancers
por: Suk, Ryan, et al.
Publicado: (2018)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

Poor knowledge – predictor of nonadherence to universal precautions for blood borne pathogens at first level care facilities in Pakistan
por: Janjua, Naveed Z, et al.
Publicado: (2007)

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

Association of COVID-19 Infection With Incident Diabetes
por: Naveed, Zaeema, et al.
Publicado: (2023)

Hepatitis-C Infection: Are we really committed to eliminate? Could it become the second Polio for Pakistan?
por: Kamani, Lubna, et al.
Publicado: (2020)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

Comparing direct acting antivirals for hepatitis C using observational data – Why and how?
por: Young, Jim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fag02rf3k5eh28djqhjggfksm2